Nomura stockbroking research has started covering the Acrux stock for the first time. I don't have their report but Dow Jones newswires says Nomura rates ACR as a buy with a price target of $3.60
(this is more than 20% above the current price)
re my own comment about AUD/USD, as the AUD has comeoff a lot lately the AUD value(to you and me) of our USD axiron sales royalties and i think milestone payments, goes up a lot too. this should ultimately flow through to AUD share price.
good luck all
ACR Price at posting:
$2.95 Sentiment: Buy Disclosure: Held
